OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
Main Authors: | Sumner-Jones, S, McCormick, D, Coles, R, Pringle, I, McLachlan, G, Collie, D, Vrettou, C, Davies, J, Alton, E, Gill, DR, Hyde, S |
---|---|
格式: | Journal article |
出版: |
2009
|
相似书籍
-
3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
由: McCormick, D, et al.
出版: (2009) -
Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.
由: Davies, L, et al.
出版: (2008) -
EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
由: Davies, J, et al.
出版: (2009) -
REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
由: Alton, E, et al.
出版: (2012) -
Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
由: Alton, E, et al.
出版: (2012)